858-251-2010 info@nucleusbiologics.com
  • LinkedIn
  • Facebook
  • Twitter
  • LinkedIn
  • Facebook
  • Twitter
0 Items
Nucleus Biologics
  • Home
  • Products
    • Physiologix™ XF SR
    • Vitronectin XF™
    • Australia FBS
    • Islet Solutions
  • Formulation Services
  • Quality
  • NB-Lux
  • Education
    • Education
    • Technical Documentation
  • Our Purpose
    • Serving Science
    • Curing Disease
    • Leadership Team
    • Board of Directors
  • FAQ
  • Contact
    • Contact Us
    • Careers
Select Page
Nucleus Biologics™ acquires Primorigen Biosciences, gains proprietary, high yield, recombinant protein platform

Nucleus Biologics™ acquires Primorigen Biosciences, gains proprietary, high yield, recombinant protein platform

by Dr. Alyssa Master | Aug 5, 2019

  Nucleus Biologics™ now has the leading xeno-free, recombinant, extracellular matrix   SAN DIEGO – August 6, 2019 – Nucleus Biologics™, a leader in precision cell culture, is pleased to announce the acquisition of Primorigen Biosciences, Inc. The addition...

Search

Tags

Cell Therapy Concierge FBS IPSCs Islet cells Media Manufacturing MSCs NB Lux Press Release Reproducibility Stem Cells T Cell Vitronectin XF
  • LinkedIn
  • Facebook
  • Twitter

Designed by Elegant Themes | Powered by WordPress